Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy

Authors: Barbara-Ann Adelstein, Petra Macaskill, Robin M Turner, Peter H Katelaris, Les Irwig

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Colonoscopy is an invasive and costly procedure with a risk of serious complications. It would therefore be useful to prioritise colonoscopies by identifying people at higher risk of either cancer or premalignant adenomas. The aim of this study is to assess a model that identifies people with colorectal cancer, advanced, large and small adenomas.

Methods

Patients seen by gastroenterologists and colorectal surgeons between April 2004 and December 2006 completed a validated, structured self-administered questionnaire prior to colonoscopy. Information was collected on symptoms, demographics and medical history. Multinomial logistic regression was used to simultaneously assess factors associated with findings on colonoscopy of cancer, advanced adenomas and adenomas sized 6 -9 mm, and ≤ 5 mm. The area under the curve of ROC curve was used to assess the incremental gain of adding demographic variables, medical history and symptoms (in that order) to a base model that included only age.

Results

Sociodemographic variables, medical history and symptoms (from 8,204 patients) jointly provide good discrimination between colorectal cancer and no abnormality (AUC 0.83), but discriminate less well between adenomas and no abnormality (AUC advanced adenoma 0.70; other adenomas 0.67). Age is the dominant risk factor for cancer and adenomas of all sizes. Having a colonoscopy within the last 10 years confers protection for cancers and advanced adenomas.

Conclusions

Our models provide guidance about which factors can assist in identifying people at higher risk of disease using easily elicited information. This would allow colonoscopy to be prioritised for those for whom it would be of most benefit.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD: Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005, 62: (6):875-883.CrossRefPubMed Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD: Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005, 62: (6):875-883.CrossRefPubMed
2.
go back to reference Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993, 328 (19): 1365-1371. 10.1056/NEJM199305133281901.CrossRefPubMed Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993, 328 (19): 1365-1371. 10.1056/NEJM199305133281901.CrossRefPubMed
3.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996, 348 (9040): 1472-1477. 10.1016/S0140-6736(96)03386-7.CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996, 348 (9040): 1472-1477. 10.1016/S0140-6736(96)03386-7.CrossRefPubMed
4.
go back to reference Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C: Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scandinavian Journal of Gastroenterology. 1994, 29 (5): 468-473. 10.3109/00365529409096840.CrossRefPubMed Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C: Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scandinavian Journal of Gastroenterology. 1994, 29 (5): 468-473. 10.3109/00365529409096840.CrossRefPubMed
5.
go back to reference Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996, 348 (9040): 1467-1471. 10.1016/S0140-6736(96)03430-7.CrossRefPubMed Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996, 348 (9040): 1467-1471. 10.1016/S0140-6736(96)03430-7.CrossRefPubMed
6.
go back to reference Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Investigators UKFST, et al: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010, 375 (9726): 1624-1633. 10.1016/S0140-6736(10)60551-X.CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Investigators UKFST, et al: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010, 375 (9726): 1624-1633. 10.1016/S0140-6736(10)60551-X.CrossRefPubMed
7.
go back to reference Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007, 1: CD001216-PubMed Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007, 1: CD001216-PubMed
8.
go back to reference Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al: The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal of Medicine. 2000, 343 (22): 1603-1607. 10.1056/NEJM200011303432203.CrossRefPubMed Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al: The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal of Medicine. 2000, 343 (22): 1603-1607. 10.1056/NEJM200011303432203.CrossRefPubMed
9.
go back to reference Levin B, Lieberman DA, American Cancer Society Colorectal Cancer Advisory G, Force USM-ST, American College of Radiology Colon Cancer C, et al: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008, 58 (3): 130-160. 10.3322/CA.2007.0018.CrossRefPubMed Levin B, Lieberman DA, American Cancer Society Colorectal Cancer Advisory G, Force USM-ST, American College of Radiology Colon Cancer C, et al: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008, 58 (3): 130-160. 10.3322/CA.2007.0018.CrossRefPubMed
10.
go back to reference Church JM: Clinical significance of small colorectal polyps. Dis Colon Rectum. 2004, 47 (4): 481-485. 10.1007/s10350-003-0078-6.CrossRefPubMed Church JM: Clinical significance of small colorectal polyps. Dis Colon Rectum. 2004, 47 (4): 481-485. 10.1007/s10350-003-0078-6.CrossRefPubMed
11.
go back to reference Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA, et al: Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010, 8 (2): 166-173. 10.1016/j.cgh.2009.10.007.CrossRefPubMed Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA, et al: Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010, 8 (2): 166-173. 10.1016/j.cgh.2009.10.007.CrossRefPubMed
12.
go back to reference Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al: Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006, 145 (12): 880-886.CrossRefPubMed Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al: Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006, 145 (12): 880-886.CrossRefPubMed
13.
go back to reference Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, et al: The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 1999, 45 (4): 588-592. 10.1136/gut.45.4.588.CrossRefPubMedPubMedCentral Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, et al: The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 1999, 45 (4): 588-592. 10.1136/gut.45.4.588.CrossRefPubMedPubMedCentral
14.
go back to reference Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FKL, et al: Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology. 2004, 127 (6): 1661-1669. 10.1053/j.gastro.2004.09.052.CrossRefPubMed Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FKL, et al: Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology. 2004, 127 (6): 1661-1669. 10.1053/j.gastro.2004.09.052.CrossRefPubMed
15.
go back to reference Adelstein BA, Irwig L, Macaskill P, Turner RM, Chan SF, Katelaris PH: Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Aliment Pharmacol Ther. 2010, 32 (2): 270-281. 10.1111/j.1365-2036.2010.04344.x.CrossRefPubMed Adelstein BA, Irwig L, Macaskill P, Turner RM, Chan SF, Katelaris PH: Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Aliment Pharmacol Ther. 2010, 32 (2): 270-281. 10.1111/j.1365-2036.2010.04344.x.CrossRefPubMed
16.
go back to reference Adelstein B-A, Irwig L, Macaskill P, Katelaris PH, Jones DB, Bokey L: A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterol. 2008, 8: 8-10.1186/1471-230X-8-8.CrossRefPubMedPubMedCentral Adelstein B-A, Irwig L, Macaskill P, Katelaris PH, Jones DB, Bokey L: A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterol. 2008, 8: 8-10.1186/1471-230X-8-8.CrossRefPubMedPubMedCentral
17.
go back to reference Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000, 343 (3): 162-168. 10.1056/NEJM200007203430301.CrossRefPubMed Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000, 343 (3): 162-168. 10.1056/NEJM200007203430301.CrossRefPubMed
18.
go back to reference Winawer SJ, Zauber AG: The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002, 12 (1): 1-9. 10.1016/S1052-5157(03)00053-9.CrossRefPubMed Winawer SJ, Zauber AG: The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002, 12 (1): 1-9. 10.1016/S1052-5157(03)00053-9.CrossRefPubMed
19.
go back to reference Mant A, Bokey EL, Chapuis PH, Killingback M, Hughes W, Koorey SG, et al: Rectal bleeding. Do other symptoms aid in diagnosis?. Dis Colon Rectum. 1989, 32 (3): 191-196. 10.1007/BF02554525.CrossRefPubMed Mant A, Bokey EL, Chapuis PH, Killingback M, Hughes W, Koorey SG, et al: Rectal bleeding. Do other symptoms aid in diagnosis?. Dis Colon Rectum. 1989, 32 (3): 191-196. 10.1007/BF02554525.CrossRefPubMed
20.
go back to reference Metcalf JV, Smith J, Jones R, Record CO: Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract. 1996, 46 (404): 161-164.PubMedPubMedCentral Metcalf JV, Smith J, Jones R, Record CO: Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract. 1996, 46 (404): 161-164.PubMedPubMedCentral
21.
go back to reference Thompson MR: ACPGBI referral guidelines for colorectal cancer. Colorectal Dis. 2002, 4: 287-297. 10.1046/j.1463-1318.2002.00348.x.CrossRefPubMed Thompson MR: ACPGBI referral guidelines for colorectal cancer. Colorectal Dis. 2002, 4: 287-297. 10.1046/j.1463-1318.2002.00348.x.CrossRefPubMed
22.
go back to reference Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D: Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet. 2002, 360 (9329): 278-283. 10.1016/S0140-6736(02)09549-1.CrossRefPubMed Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D: Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet. 2002, 360 (9329): 278-283. 10.1016/S0140-6736(02)09549-1.CrossRefPubMed
23.
go back to reference O'Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, et al: Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999, 319 (7212): 731-734.CrossRefPubMedPubMedCentral O'Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, et al: Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999, 319 (7212): 731-734.CrossRefPubMedPubMedCentral
24.
go back to reference Ballal MS, Selvachandran SN, Maw A: Use of a patient consultation questionnaire and weighted numerical scoring system for the prediction of colorectal cancer and other colorectal pathology in symptomatic patients: a prospective cohort validation study of a Welsh population. Colorectal Dis. 2010, 12 (5): 407-414. 10.1111/j.1463-1318.2009.01984.x.CrossRefPubMed Ballal MS, Selvachandran SN, Maw A: Use of a patient consultation questionnaire and weighted numerical scoring system for the prediction of colorectal cancer and other colorectal pathology in symptomatic patients: a prospective cohort validation study of a Welsh population. Colorectal Dis. 2010, 12 (5): 407-414. 10.1111/j.1463-1318.2009.01984.x.CrossRefPubMed
25.
go back to reference Thompson MR, Perera R, Senapati A, Dodds S: Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg. 2007, 94 (10): 1260-1265. 10.1002/bjs.5826.CrossRefPubMed Thompson MR, Perera R, Senapati A, Dodds S: Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg. 2007, 94 (10): 1260-1265. 10.1002/bjs.5826.CrossRefPubMed
26.
go back to reference Tan YM, Rosmawati M, Ranjeev P, Goh KL: Predictive factors by multivariate analysis for colorectal cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol. 2002, 17 (3): 281-284. 10.1046/j.1440-1746.2002.02694.x.CrossRefPubMed Tan YM, Rosmawati M, Ranjeev P, Goh KL: Predictive factors by multivariate analysis for colorectal cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol. 2002, 17 (3): 281-284. 10.1046/j.1440-1746.2002.02694.x.CrossRefPubMed
27.
go back to reference Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, et al: Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther. 2009, 29 (8): 906-917. 10.1111/j.1365-2036.2009.03946.x.CrossRefPubMed Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, et al: Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther. 2009, 29 (8): 906-917. 10.1111/j.1365-2036.2009.03946.x.CrossRefPubMed
28.
go back to reference Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003, 56 (11): 1129-1135. 10.1016/S0895-4356(03)00177-X.CrossRefPubMed Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003, 56 (11): 1129-1135. 10.1016/S0895-4356(03)00177-X.CrossRefPubMed
Metadata
Title
The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy
Authors
Barbara-Ann Adelstein
Petra Macaskill
Robin M Turner
Peter H Katelaris
Les Irwig
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-97

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue